期刊文献+

EB病毒相关淋巴母细胞样细胞系的建立及鉴定 被引量:3

Development and identification of lymphoblastoid cell lines associated with Epstein-Barr virus
下载PDF
导出
摘要 目的由于EB病毒与肿瘤的关系极为复杂且存在争议,淋巴母细胞样细胞系LCLs(lymphoblastoid celllines)没有肿瘤形成过程中的复杂因素,从而成为了研究EBV介导的细胞永生化的最佳模型。本实验旨在建立EBV原型株相关的永生化淋巴母细胞系,为后期LCLs的端粒酶活性及其体内外成瘤性的相关研究提供基础。方法利用体外培养B95.8细胞产生EB病毒原型株感染正常人外周血淋巴细胞培养传代得到5株EB病毒相关淋巴母细胞,并用RT-PCR对其进行了基因表达、流式细胞仪进行细胞表面标记以及核型的鉴定。结果淋巴母细胞样细胞系能不断传代,能表达EBV基因,具有成熟B细胞表面标记;细胞传代过程早期未发生核型改变。结论建立了5株永生化细胞株,分别为LCL1-5、LCL2-5、LCL3-5、LCL4-30、LCL5-30。 Objective The relation between Epstein-Barr virus and tumor is complicated and disputable. Lymphoblastoid cell lines (LCLs) have become the best model in the studies on tumorgenesis and cell immortalization associated with EBV because of its relatively simple process, furthermore some characters of B lymphocyte make LCLs important in the researches in immunology. In this paper, we aimed to develop LCLs associated with EBV to carry on our following experiments on the telomerase activity and tumorgenesis in vivo and in vitro. Methods Normal peripheral blood lymphocytes were transformed with EBV prototype produced by B95.8 cell; LCLs were identified in gene expression of EBV by RT-PCR, and cell surface marker and karyotype were also detected. Results 5 strains of LCLs could be subcultured continently with normal karyote, EBV associated latent membrane protein gene and CD19 could be dected in all of the five cell lines. Conclusion five strains of LCLs were developed and named respectively with LCL1-5, LCL2-5, LCL3-5, LCL4-30,LCL5-30.
出处 《分子诊断与治疗杂志》 2010年第1期31-34,共4页 Journal of Molecular Diagnostics and Therapy
关键词 EB病毒 永生化 转化细胞系 淋巴细胞 Epstein-Barr virus Immortalization Transformed cell lines Lymphocyte
  • 相关文献

参考文献12

二级参考文献32

  • 1罗挺,凌淑清,刘若英,吴绍熙,林得宝,李杰.进行性色素过度沉着症一个汉族家系的研究[J].中华医学遗传学杂志,1994,11(3):174-175. 被引量:2
  • 2陈阳,高建华,刘晓军,严欣,宋玫.瘢痕疙瘩中国家系的发病特点研究[J].中国美容医学,2006,15(1):6-10. 被引量:20
  • 3Cosman B,Crikelair GF,Ju DM,et al.The surgical treatment of keloids[J].Plast Reconst Surg,1961,27(6):335-338.
  • 4Marneros AG,Norris JE,Olsen BR,et al.Clinical genetics of familial keloids[J].Arch Dermatol,2001,137(11):1429-1434.
  • 5Aman P,Gordon J,Nordstrom M,et al.Surface marker characterization of EBV-susceptible B-lymphocyte populations[J].J Immunol,1985,135(4):1154.
  • 6Shannon-Lowe C,Baldwin G,Feederle R,et al.Epstein-Barr virus-induced B-cell transformation:Quantitating events from virus binding to cell outgrowth[J].J Gen Virol,2005,86(Pt 11):3009-3019.
  • 7AndreasM,Naeem K,Mark C,et al.B cells immortalized by amini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells[J].Blood,2002,100(5):1755-1764.
  • 8Moss DJ,Burrows SR,Silins SL,et al.The immunology of Epstein-Barr virus infection[J].Philos Trans R Soc Lond B Biol Sci,2001,356(1408):475-488.
  • 9Wilson AD,Irina R,WilliamsNA,et al.CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand mediated apoptosis[J].Int Immunol,1998,10(8):1149-1157.
  • 10Brack C,Mattaj IW,Gautschi J,et al.Cyclosporin A is a differential inhibitor of eukaryotic RNA polymerases[J].Exp Cell Res,1984,151:314-321.

共引文献11

同被引文献31

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部